Neoplastic disease after heart transplantation: single center experience.

[1]  C. Marboe,et al.  The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  V. Reddy,et al.  Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. , 1996, Clinical transplantation.

[3]  B. Griffith,et al.  Solid tumors after heart transplantation: lethality of lung cancer. , 1995, The Annals of thoracic surgery.

[4]  M. Oz,et al.  De novo solid malignancies after cardiac transplantation. , 1995, The Annals of thoracic surgery.

[5]  I. Penn.  Solid tumors in cardiac allograft recipients. , 1995, The Annals of thoracic surgery.

[6]  K. Naunheim,et al.  Primary bronchogenic carcinoma in the heart transplant recipient. , 1994, The Annals of thoracic surgery.

[7]  T. Levine,et al.  Prospective evaluation of malignant neoplasms in cardiac transplant recipients uniformly treated with prophylactic antilymphocyte globulin. , 1993, The Journal of thoracic and cardiovascular surgery.

[8]  I. Penn.  Incidence and treatment of neoplasia after transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  D. Farge.  Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. , 1993, The European journal of medicine.

[10]  B. Griffith,et al.  Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  R. Fisher,et al.  Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. , 1990, The New England journal of medicine.

[12]  I. Penn.  Cancers complicating organ transplantation. , 1990, The New England journal of medicine.

[13]  W. S. Ring,et al.  Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression. , 1990, The Journal of heart transplantation.

[14]  T. English,et al.  Malignant tumors after heart transplantation. , 1990, The Journal of heart transplantation.

[15]  J. Tobacman,et al.  INCREASED FREQUENCY OF POSTTRANSPLANT LYMPHOMAS IN PATIENTS TREATED WITH CYCLOSPORINE, AZATHIOPRINE, AND PREDNISONE , 1989, Transplantation.

[16]  H. Bretschneider,et al.  Kidney procurement with the HTK solution of Bretschneider. , 1988, Transplantation proceedings.

[17]  W. Cole.  The increase in immunosuppression and its role in the development of malignant lesions , 1985, Journal of surgical oncology.

[18]  T. Starzl,et al.  REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY , 1984, The Lancet.

[19]  W. Blattner,et al.  Association of cigarette smoking with decreased numbers of circulating natural killer cells. , 1989, The American review of respiratory disease.

[20]  D. Howell,et al.  Phenotype and function of T cells propagated from donor-specific blood transfusion enhanced and autologous blood transfused rejecting rat renal allografts. , 1988, Transplantation proceedings.